ODDO BHF Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

ODDO BHF Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,100,000	Closed	-$15.5M	–	407
2024 Q4	$15.5M	Buy	5,100,000 +4,375,000	+603%	+$19.1M	0.78%	33
2024 Q3	$3.76M	Buy	+725,000	New	+$3.6M	0.19%	103

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ODDO BHF Asset Management's RVNC Position: Q1 2025 in Review

ODDO BHF Asset Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 5,100,000 shares — an estimated $15.5M sold.

ODDO BHF Asset Management first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $15.5M in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

ODDO BHF Asset Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
ODDO BHF Asset Management sold 5,100,000 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $15.5M.
ODDO BHF Asset Management first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
ODDO BHF Asset Management's Revance Therapeutics, Inc. position peaked at $15.5M in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on ODDO BHF Asset Management's 13F filing for Q1 2025, filed 12 May 2025.